Genetic Technologies Limited announced that Mr. Michael Tonroe has resigned as Chief Financial Officer of the Company to pursue other opportunities. The Company will commence a search process for a new CFO with requisite dual ASX and Nasdaq listed company expertise, with a specific focus on managing global sales and will provide a further market update in due course. Mr. Tonroe will remain CFO until the completion of the transition of duties to an interim or permanent replacement with global sales experience will be actively recruited.